Hepatic venous pressure in practice: How, when, and why

Journal of Clinical Gastroenterology

Volumn 41, Issue SUPPL. 3, 2007, Pages

  Vorobioff, Julio D ^a,b  

^a UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^b NONE   (Argentina)

Author keywords

Pharmacologic therapy; Portal hypertension; Portal pressure measurement

Indexed keywords

BLOOD PRESSURE MEASUREMENT; CALIBRATION; CLINICAL RESEARCH; CONFERENCE PAPER; DIAGNOSTIC VALUE; DISEASE COURSE; ENDOSCOPIC SCLEROTHERAPY; ESOPHAGUS VARICES; ESOPHAGUS VARICES BLEEDING; HEPATIC VEIN; HUMAN; LIGATION; LIVER CIRCULATION; OUTCOME ASSESSMENT; PORTAL HYPERTENSION; PORTAL VEIN BLOOD PRESSURE; PREDICTION; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROGNOSIS; STOMACH VARICES; SURGICAL RISK; SURVIVAL; VENOUS PRESSURE;

BALLOON DILATATION; BLOOD PRESSURE DETERMINATION; CALIBRATION; EQUIPMENT DESIGN; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HUMANS; HYPERTENSION, PORTAL; MANOMETRY; PORTAL PRESSURE; PRACTICE GUIDELINES AS TOPIC; PREDICTIVE VALUE OF TESTS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 35848945892     PISSN: 01920790     EISSN: None     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31814684d3     Document Type: Conference Paper

References (61)

1. Groszmann RJ, de Franchis R. Portal hypertension. In: Schiff ER, Sorrell MF, Maddrey W, eds. Schiff's Diseases of the Liver. Philadelphia: Lippincott-Raven Publishers; 1999:342-387.
2. Groszmann RJ, Atterbury CE. Clinical applications of the measurement of portal venous pressure. J Clin Gastroenetrol. 1980;2:379-386.
3. D'Amico G, García-Tsao G, Calès P, et al. Diagnosis of portal hypertension. How and when? In: de Franchis R, ed. Portal Hypertension III. Proceedings of the Third Baveno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies. Oxford: Blackwell Science; 2001:36-64.
4. Hallion L, Francois-Frank CA. Recherches experimentales executees a l'aide d'um novel appareil volumetrique sur l'innervation vaso-motrice de l'intestin. Arch Physiol Norm Pathol. 1896;8:493-508.
5. Thompson WP, Caughey JL, Whipple AO, et al. Splenic vein pressure and congestive splenomegaly (Banty's syndrome). J Clin Invest. 1937;16:571-576.
6. Myers JD, Taylor WJ. An estimation of portal venous pressure by occlusive catheterization of a hepatic venule. J Clin Invest. 1951;30:662-663.
7. Vorobioff J, Abraldes JG, Groszmann RJ. Hepatic venous pressure gradient: the facts. In: Groszmann RJ, Bosch J, eds. Portal Hypertension in the 21st Century. Dordretch: Kluwer Academic Publishers; 2004:309-322.
8. Groszmann RJ, Glickman MC, Blei AT, et al. Wedged and free hepatic venous pressure measured with a balloon catheter. Gastroenterology. 1979;76:253-258.
9. Groszmann R, Wongcharatrawee S. The hepatic venous pressure gradient: anything worth doing should be done right. Hepatology. 2004;39:280-282.
10. Bosch J, Mastai R, Kravetz D, et al. Hemodynamic evaluation in patients with portal hypertension. Semin Liver Dis. 1986;6:309-317.
11. Seinlauf AF, García-Tsao G, Gupta T, et al. Low-dose midazolam sedation: an option for patients undergoing serial hepatic venous pressure measurements. Hepatology. 1999;29:1070-1073.
12. Boyer T, Triger DR, Horisawa M, et al. Direct transhepatic measurement of portal vein pressure using a thin needle. Gastroenterology. 1977;72:584-589.
13. Pomier-Layrargues G, Kusielewicz D, Willems B, et al. Presinusoidal portal hypertension in non-alcoholic cirrhosis. Hepatology. 1985;5:415-418.
14. Perello A, Escorsell A, Bru C, et al. Wedged hepatic venous pressure adequately reflects portal pressure in hepatitis C virus-related cirrhosis. Hepatology. 1999;30:1393-1397.
15. Loureiro-Silva MR, Cadelina GW, Groszmann RJ. Deficit in nitric oxide production in cirrhotic rat livers is located in the sinusoidal and postsinusoidal areas. Am J Physiol Gastrointest Liver Physiol. 2003;284:G567-G574.
16. Groszmann RJ, García-Tsao G, Bosch J, et al. Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis. N Engl J Med. 2005;353:2254-2261.
17. García-Tsao G, Groszmann RJ, Fisher RL, et al. Portal pressure, presence of gastroesophageal varices and variceal bleeding. Hepatology. 1985;5:419-424.
18. Rigau J, Bosch J, Bordas JM, et al. Endoscopic measurement of variceal pressure in cirrhosis: correlation with portal pressure and variceal hemorrhage. Gastroenterology. 1989;96:873-880.
19. Viallet A, Marleau D, Huet M, et al. Hemodynamic evaluation of patients with intrahepatic portal hypertension. Relationship between bleeding varices and the portohepatic gradient. Gastroenterology. 1975;69:1297-1300.
20. Pomier-Layrargues G, Villeneuve JP, Willems B, et al. Systemic and hepatic hemodynamics after variceal hemorrhage: effects of propranolol and placebo. Gastroenterology. 1987;93:1218-1224.
21. Gluud C, Henriksen JH, Nielsen G. Prognostic indicators in alcoholic cirrhotic men. Hepatology. 1988;8:222-227.
22. Merkel C, Bolognesi M, Bellon S, et al. Prognostic usefulness of hepatic vein catheterization in patients with cirrhosis and esophageal varices. Gastroenterology. 1992;102:973-979.
23. Viola C, Bosch J, Mastai R, et al. Prognostic value of measurements of portal pressure in patients with cirrhosis [Abstract]. J Hepatol. 1987;5(suppl 1):S71.
24. Vlavianos P, Gimson AES, Hayllar K, et al. Prognostic significance of systemic and portal hemodynamic parameters in patients with cirrhosis and previous variceal bleeding [Abstract]. Gut. 1990;31:A592.
25. Lebrec D, De Fleury P, Rueff B, et al. Portal hypertension, size of esophageal varices, and risk of gastrointestinal bleeding in alcoholic cirrhosis. Gastroenterology. 1980;79:1139-1144.
26. Vorobioff J, Groszmann RJ, Picabea E, et al. Prognostic value of hepatic venous pressure measurement in alcoholic cirrhosis: a ten year prospective study. Gastroenterology. 1996;111:701-709.
27. Adamson RJ, Butt K, Dennis CR, et al. Prognostic significance of portal pressure in patients with bleeding esophageal varices. Surg Gynecol Obstet. 1977;145:353-356.
28. Ready JB, Robertson AD, Goff JS, et al. Assessment of the risk of bleeding from esophageal varices by continuous monitoring of portal pressure. Gastroenterology. 1991;100:1403-1410.
29. Moitinho E, Escorsell A, Bandi JC, et al. Prognostic value of early measurements of portal pressure in acute variceal bleeding. Gastroenterology. 1999;117:626-631.
30. Villanueva C, Ortiz J, Miñana J, et al. Somatostatin treatment and risk stratification by continuous portal pressure monitoring during acute variceal bleeding. Gastroenterology. 2001;121:110-117.
31. Groszmann RJ, Bosch J, Grace N, et al. Hemodynamic events in a prospective randomized trial of propranolol versus placebo in the prevention of a first variceal hemorrhage. Gastroenterology. 1990;99:1401-1407.
32. Abraldes JG, Tarantino I, Turnes J, et al. Hemodynamic response to pharmacological treatment of portal hypertension and long-term prognosis of cirrhosis. Hepatology. 2003;37:902-908.
33. Patch D, Armonis A, Sabin C, et al. Single portal pressure measurement predicts survival in cirrhotic patients with recent bleeding. Gut. 1999;44:264-269.
34. Arroyo V, Bosch J, Gaya-Beltran J, et al. Plasma renin activity and urinary sodium excretion as prognostic indicators in nonazotemic cirrhosis with ascites. Ann Intern Med. 1981;94:198-201.
35. Vinel JP, Cassigneul J, Louis A, et al. Clinical and prognostic significance of portohepatic gradient in patients with cirrhosis. Surg Gynecol Obstet. 1982;155:347-352.
36. Vinel JP, Cassigneul J, Levade M, et al. Assessment of short-term prognosis after variceal bleeding in patients with alcoholic cirrhosis by early measurement of portohepatic gradient. Hepatology. 1986;6:116-117.
37. Tage-Jensen U, Henriksen JH, Christensen E, et al. Plasma catecholamine level and portal venous pressure as guides to prognosis in patients with cirrhosis. J Hepatol. 1988;6:350-358.
38. Villanueva C, Aracil C, Lopez-Balaguer JM, et al. Nadolol plus isosorbide mononitrate compared with sclerotherapy for the prevention of variceal rebleeding. N Engl J Med. 1996;334:1624-1629.
39. Villanueva C, López-Balaguer JM, Aracil C, et al. Maintenance of hemodynamic response to treatment for portal hypertension and influence on complications of cirrhosis. J Hepatol. 2004;40:757-765.
40. Leevy CM, Zinke M, Baber J, et al. Observations on the influence of medical therapy on portal hypertension in hepatic cirrhosis. Ann Intern Med. 1958;49:837-851.
41. Reynolds TB, Geller HM, Kuzma OT, et al. Spontaneous decrease in portal pressure with clinical improvement in cirrhosis. N Engl J Med. 1960;263:734-739.
42. García-Tsao G, Rodríguez Pérez F, Blei AT, et al. Treatment with interferon reduces portal pressure in patients with chronic hepatitis C. A randomized, placebo trial. Gastroenterology. 1996;10:A1193.
43. Rincon D, Ripoll C, Lo Iacono O, et al. Antiviral therapy decreases hepatic venous pressure gradient in patients with chronic hepatitis C and advanced cirrhosis. Am J Gastroenterol. 2006;101:2269-2274.
44. Blasco A, Forns X, Carrión JA, et al. Hepatic venous pressure gradient identifies patients at risk of severe hepatitis C recurrence after liver transplantation. Hepatology. 2006;43:492-499.
45. Carrión JA, Navasa M, García-Retortillo M, et al. Efficacy of antiviral therapy on hepatitis C recurrente alter liver transplantation. A randomized controlled study. Gastroenterology. 2007;132:1746-1756.
46. Morali GA, Sniderman KW, Deitel KM, et al. Is sinusoidal portal hypertension a necessary factor for the development of hepatic ascites? J Hepatol. 1992;16:249-250.
47. Rector WG Jr. Portal hypertension: a permissive factor only in the development of ascites and variceal bleeding. Liver. 1986;6:221-226.
48. Feu F, García-Pagán JC, Bosch J, et al. Relation between portal pressure response to pharmacotherapy and risk of recurrent variceal hemorrhage in patients with cirrhosis. Lancet. 1995;346:1056-1059.
49. McCormick PA, Patch D, Greenslade L, et al. Clinical vs hemodynamic response to drugs in portal hypertension. J Hepatol. 1998;28:1015-1019.
50. Villanueva C, Minana J, Ortiz J, et al. Endoscopic ligation compared with combined treatment with nadolol and isosorbide mononitrate to prevent recurrent variceal bleeding. N Engl J Med. 2001;345:647-655.
51. Merkel C, Bolognesi M, Sacerdoti D, et al. The hemodynamic response to medical treatment of portal hypertension as a predictor of clinical effectiveness in the primary prophylaxis of variceal bleeding in cirrhosis. Hepatology. 2000;32:930-934.
52. Bureau C, Péron JM, Alric L, et al. "A la Carte" treatment of portal hypertension: adapting medical therapy to hemodynamic response for the prevention of bleeding. Hepatology. 2002;36:1361-1366.
53. Patch D, Sabin CA, Goulis J, et al. A randomized, controlled trial of medical therapy versus endoscopic ligation for the prevention of variceal rebleeding in patients with cirrhosis. Gastroenterology. 2002;123:1013-1019.
54. Groszmann RJ, García-Tsao G. Endoscopic variceal banding vs. pharmacological therapy for the prevention of recurrent variceal hemorrhage: what makes the difference? Gastroenterology. 2002;123:1388-1391.
55. Friedman LS, Maddrey WC. Surgery in the patient with liver disease. Med Clin N Am. 1987;71:453-476.
56. Teh SH, Nagorney DM, Stevens SR, et al. Risk factors for mortality after surgery in patients with cirrhosis. Gastroenterology. 2007;132:1261-1269.
57. Bruix J, Castells A, Bosch J, et al. Surgical resection of hepatocellular carcinoma in cirrhotic patients. Prognostic value of preoperative portal pressure. Gastroenterology. 1996;111:1018-1022.
58. Llovet JM, Fuster J, Bruix J. Intention-to-treat analysis of surgical treatment for early hepatocellular carcinoma: resection versus transplantation. Hepatology. 1999;30:1434-1430.
59. Lovet JM, Bruix J, Fuster J, et al. Liver transplantation for small hepatocellular carcinoma: the tumor-node-metastasis classification does not have prognosis power. Hepatology. 1998;27:1572-1577.
60. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693-699.
61. Bismuth H, Chiche L, Adam R, et al. Liver resection versus transplantation for hepatocellular carcinoma in cirrhotic patients. Ann Surg. 1993;218:145-151.